This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Apr;29(4):514-516.

doi: 10.1016/j.cardfail.2023.01.008.

The (Pluri)Potential of Cell Therapy for Heart Failure

Lauren Parker¹, Ravi Karra²

Affiliations

Affiliations

¹ Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC.
² Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC; Department of Pathology, Duke University Medical Center, Durham, NC; Duke Regeneration Center, Duke University, Durham, NC.. Electronic address: ravi.karra@duke.edu.

PMID: 37059513
DOI: 10.1016/j.cardfail.2023.01.008

Comment

The (Pluri)Potential of Cell Therapy for Heart Failure

Lauren Parker et al. J Card Fail. 2023 Apr.

. 2023 Apr;29(4):514-516.

doi: 10.1016/j.cardfail.2023.01.008.

Authors

Lauren Parker¹, Ravi Karra²

Affiliations

¹ Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC.
² Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC; Department of Pathology, Duke University Medical Center, Durham, NC; Duke Regeneration Center, Duke University, Durham, NC.. Electronic address: ravi.karra@duke.edu.

PMID: 37059513
DOI: 10.1016/j.cardfail.2023.01.008

No abstract available

Keywords: Heart failure; cell therapy; regeneration; stem cell.

PubMed Disclaimer

Conflict of interest statement

Disclosures None.

Comment on

Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells for Heart Failure: A State-of-the-Art Review.
Kishino Y, Tohyama S, Morita Y, Soma Y, Tani H, Okada M, Kanazawa H, Fukuda K. Kishino Y, et al. J Card Fail. 2023 Apr;29(4):503-513. doi: 10.1016/j.cardfail.2022.10.433. J Card Fail. 2023. PMID: 37059512 Review.

Similar articles

Combined usage of stem cells in end-stage heart failure therapies.
Wang X, Zachman AL, Haglund NA, Maltais S, Sung HJ. Wang X, et al. J Cell Biochem. 2014 Jul;115(7):1217-24. doi: 10.1002/jcb.24782. J Cell Biochem. 2014. PMID: 24753018 Review.
[Stem cell therapy and heart failure: hopes and disappointments].
Desnos M. Desnos M. Bull Acad Natl Med. 2014 Jan;198(1):71-82; discussion 82-3. Bull Acad Natl Med. 2014. PMID: 26259288 French.
Myocyte renewal and therapeutic myocardial regeneration using various progenitor cells.
Hayashi E, Hosoda T. Hayashi E, et al. Heart Fail Rev. 2014 Nov;19(6):789-97. doi: 10.1007/s10741-014-9430-2. Heart Fail Rev. 2014. PMID: 24743881 Review.
Medicine. Cardiac regeneration.
Rosenzweig A. Rosenzweig A. Science. 2012 Dec 21;338(6114):1549-50. doi: 10.1126/science.1228951. Science. 2012. PMID: 23258880 No abstract available.
[Stem cell therapy for the regeneration of heart muscle].
Steinhoff G. Steinhoff G. Internist (Berl). 2006 May;47(5):479-80, 482-4, 486-7. doi: 10.1007/s00108-006-1610-2. Internist (Berl). 2006. PMID: 16557410 German.

See all similar articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

R01 HL157277/HL/NHLBI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information